Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-15-376922

← back to feed
Filed
Nov 13, 2015 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Nov 13, 2015 30.83M sh
Capex Q3 2015 · Sep 30, 2015 $1.39K
Capex Q3 2015 · Sep 30, 2014 $5.62K
Operating Cash Flow Q3 2015 · Sep 30, 2015 −$1.07M
Operating Cash Flow Q3 2015 · Sep 30, 2014 −$1.08M
Cash And Equivalents Q3 2015 · Sep 30, 2015 $23.22K
Cash And Equivalents Q3 2015 · Dec 31, 2014 $707.01K
Cash And Equivalents Q3 2015 · Sep 30, 2014 $1.09M
Cash And Equivalents Q3 2015 · Dec 31, 2013 $142.53K
Stockholders Equity Q3 2015 · Sep 30, 2015 −$2.01M
Stockholders Equity Q3 2015 · Dec 31, 2014 −$295.85K
Current Liabilities Q3 2015 · Sep 30, 2015 $1.77M
Current Liabilities Q3 2015 · Dec 31, 2014 $1.04M
Total Liabilities Q3 2015 · Sep 30, 2015 $2.09M
Total Liabilities Q3 2015 · Dec 31, 2014 $1.04M
Current Assets Q3 2015 · Sep 30, 2015 $61.28K
Current Assets Q3 2015 · Dec 31, 2014 $721.74K
Total Assets Q3 2015 · Sep 30, 2015 $81.6K
Total Assets Q3 2015 · Dec 31, 2014 $748.31K
Sga Expense Q3 2015 · Sep 30, 2015 $742.08K
Sga Expense Q3 2015 · Sep 30, 2015 $1.84M
Sga Expense Q3 2015 · Sep 30, 2014 $429.54K
Sga Expense Q3 2015 · Sep 30, 2014 $1.48M
Rd Expense Q3 2015 · Sep 30, 2015 $243.05K
Rd Expense Q3 2015 · Sep 30, 2015 $731.23K
Rd Expense Q3 2015 · Sep 30, 2014 $374.94K
Rd Expense Q3 2015 · Sep 30, 2014 $1.64M
Net Income Q3 2015 · Sep 30, 2015 −$1M
Net Income Q3 2015 · Sep 30, 2015 −$2.57M
Net Income Q3 2015 · Sep 30, 2014 −$619.75K
Net Income Q3 2015 · Sep 30, 2014 −$2.52M
Operating Income Q3 2015 · Sep 30, 2015 −$985.13K
Operating Income Q3 2015 · Sep 30, 2015 −$2.58M
Operating Income Q3 2015 · Sep 30, 2014 −$637.24K
Operating Income Q3 2015 · Sep 30, 2014 −$2.46M
Gross Profit Q3 2015 · Sep 30, 2014 $167.24K
Gross Profit Q3 2015 · Sep 30, 2014 $669.06K
Cost Of Revenue Q3 2015 · Sep 30, 2014 $800